Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. 4 Grant or award Director acquired 25,000 shares (grant or award)
  2. 4 Grant or award Director acquired 25,000 shares (grant or award)
  3. 4 Grant or award Director acquired 25,000 shares (grant or award)
  4. 4 Grant or award Director acquired 25,000 shares (grant or award)
  5. 4 Open-market buy Chief Financial Officer bought 1,250 shares at $20.03 ($25,037)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Chief Executive Officer acquired 146,250 shares (grant or award)
  9. 4 Other acquisition Chief Financial Officer acquired 2,045 shares (other)
  10. 4 Grant or award President, Head of R&D acquired 47,813 shares (grant or award)
  11. 4 Grant or award Director acquired 17,000 shares (grant or award)
  12. 4 Grant or award Director acquired 17,000 shares (grant or award)
  13. 4 Grant or award Director acquired 17,000 shares (grant or award)
  14. 4 Grant or award Director acquired 17,000 shares (grant or award)
  15. 4 Grant or award Director acquired 17,000 shares (grant or award)
  16. 4 Grant or award Director acquired 34,000 shares (grant or award)
  17. 4 Grant or award Director acquired 17,000 shares (grant or award)
  18. 4 Planned sale Director sold 52,855 shares at $18.27 ($965,402)
  19. 4 Planned sale Director sold 83,000 shares at an average $20.46 ($1,697,810)
  20. 4 Planned sale Director sold 52,855 shares at $20.40 ($1,078,068)

Page 3 of 13 · 259 filings